BLOOMIOS, INC. (BLMS) Financial Statements (2024 and earlier)

Company Profile

Business Address 701 ANACAPA STREET, SUITE C
SANTA BARBARA, CA 93101
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
1/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25027172 
Cash and cash equivalents25027172 
Inventory, net of allowances, customer advances and progress billings1,772512  
Inventory1,772512  
Prepaid expense 29   
Other undisclosed current assets394731379 
Total current assets:2,4441,514451 
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization57214  
Property, plant and equipment1,5271,8622,070 
Intangible assets, net (including goodwill)21,865300300 
Goodwill21,865300300 
Other undisclosed noncurrent assets117117373 
Total noncurrent assets:23,5672,4942,743 
TOTAL ASSETS:26,0114,0073,194 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,5062,2601,748 
Accounts payable2,3422,2361,748 
Accrued liabilities16423  
Debt588946352 
Due to related parties19,96492121 
Other undisclosed current liabilities4,1242,0311,262 
Total current liabilities:27,1825,3273,483 
Noncurrent Liabilities
Long-term debt and lease obligation150250  
Long-term debt, excluding current maturities 150150  
Finance lease, liability 100  
Liabilities, other than long-term debt   150 
Deferred revenue   150 
Other undisclosed noncurrent liabilities  824 
Total noncurrent liabilities:150250974 
Total liabilities:27,3325,5774,458 
Equity
Equity, attributable to parent, including:(1,321)(1,570)(1,264) 
Common stock0000
Additional paid in capital6,4354,7043,0602,680
Accumulated deficit(20,110)(6,335)(4,324)(2,680)
Other undisclosed equity, attributable to parent12,35462  
Other undisclosed equity    
Total equity:(1,321)(1,570)(1,264) 
Other undisclosed liabilities and equity    
TOTAL LIABILITIES AND EQUITY:26,0114,0073,194 

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
1/31/2020
Revenues6,0778,492  
Cost of revenue
(Cost of Goods and Services Sold)
(3,849)(4,708)(915) 
Other undisclosed gross profit   1,316 
Gross profit:2,2283,783402 
Operating expenses(6,368)(4,584)(1,464)(17)
Operating loss:(4,140)(800)(1,063)(17)
Interest and debt expense(61)60(71) 
Loss from continuing operations before equity method investments, income taxes:(4,201)(740)(1,134)(17)
Other undisclosed loss from continuing operations before income taxes(9,573)(1,271)(37) 
Loss from continuing operations:(13,774)(2,011)(1,171)(17)
Loss before gain (loss) on sale of properties:(2,011)(1,171)(17)
Other undisclosed net loss(0)   
Net loss:(13,774)(2,011)(1,171)(17)
Other undisclosed net income (loss) attributable to parent0(0)  
Net loss available to common stockholders, diluted:(13,774)(2,011)(1,171)(17)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
1/31/2020
Net loss:(13,774)(2,011)(1,171)(17)
Comprehensive loss, net of tax, attributable to parent:(13,774)(2,011)(1,171)(17)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: